Pfizer Inc.
Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme

Last updated:

Abstract:

Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

7 Jul 2017

Issue date:

2 Feb 2021